These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2045531)

  • 1. The immunosuppressive activity of the aldehydic transformation of cyclosporine on alloreactive T-cells.
    Eiras G; Hashem H; Zeevi A; Wong L; Duquesnoy RJ; Burckart GJ
    J Clin Pharmacol; 1991 Jan; 31(1):72-5. PubMed ID: 2045531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites.
    Zeevi A; Venkataramanan R; Burckart G; Wang CP; Murase N; Van Thiel DH; Starzl TE; Makowka L; Duquesnoy RJ
    Hum Immunol; 1988 Feb; 21(2):143-53. PubMed ID: 2966788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
    Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
    Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of cyclosporine metabolites.
    Yatscoff RW; Rosano TG; Bowers LD
    Clin Biochem; 1991 Feb; 24(1):23-35. PubMed ID: 2060129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the binding of cyclosporine to calmodulin result in immunosuppression?
    LeGrue SJ; Turner R; Weisbrodt N; Dedman JR
    Science; 1986 Oct; 234(4772):68-71. PubMed ID: 3749892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of immunosuppression by cyclosporins.
    Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.
    Russell DH; Kibler R; Matrisian L; Larson DF; Poulos B; Magun BE
    J Immunol; 1985 May; 134(5):3027-31. PubMed ID: 2984281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
    Citterio F; Kahan BD
    Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro immunosuppressive properties of cyclosporine metabolites.
    Freed BM; Rosano TG; Lempert N
    Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells.
    Zeevi A; Eiras G; Burckart G; Makowka L; Venkataramanan R; Wang CP; Van Thiel DH; Murase N; Starzl TE; Duquesnoy R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):115-21. PubMed ID: 2966474
    [No Abstract]   [Full Text] [Related]  

  • 18. Difference in sensitivity to cyclosporine in vitro of human alloreactive lines and clones.
    Manca F; Carrozzi S; Kunkl A; Barocci S; Dessi V; Valente U; Fontana I; Celada F
    Transplantation; 1986 Feb; 41(2):199-203. PubMed ID: 3003976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity.
    Weiss J; Schwinzer B; Kirchner H; Gemsa D; Resch K
    Immunobiology; 1986 Apr; 171(3):234-51. PubMed ID: 3086216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal differentiation of thymocytes in mice treated with cyclosporin A.
    Gao EK; Lo D; Cheney R; Kanagawa O; Sprent J
    Nature; 1988 Nov; 336(6195):176-9. PubMed ID: 2972933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.